FORTY Q1 2025 Earnings EPS of 123 Reported Amid Stock Decline Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus Radian Group Q1 2026 Earnings BEPS Beat Estimates Despite Broader Market Headwinds RDCM Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Market Reaction HCM Q2 2023 Earnings Significant EPS Beat Driven by Operational Progress HRB Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction